Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Chemicals

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

Revenue projections:

Revenue projections for ACI
Revenue projections for ACI

ACI's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 0.00000
forwardPE 21.53077
debtToEquity 14.78200
earningsGrowth -0.50500
revenueGrowth 0.05100
grossMargins 0.95173
operatingMargins 0.12097
trailingEps 11.87000
forwardEps 26.00000

ACI's Forward PE ratio is favorable, indicating that the stock price is well-positioned in relation to its earnings. It is not overpriced, leaving room for growth, which makes it a solid option for investors seeking both stability and future appreciation.
ACI's low Debt-to-Equity ratio shows the company avoids heavy reliance on debt. This balanced approach reduces financial risk, as it maintains a healthy equity position without excessive leverage, providing greater financial stability and flexibility.
ACI's low earnings and revenue growth suggest that the company may see declining profits. This indicates potential financial challenges ahead, and could lead to a more cautious outlook from investors.
ACI's negative gross and operating margins indicate that the company is not generating profit from either production or day-to-day operations. This could suggest cost overruns or declining revenue, impacting its financial stability.
Archean Chemical Industries Limited's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for ACI
Price projections for ACI

ACI's price has consistently remained near the lower edge of projections, suggesting that it is not fully meeting market expectations. This could indicate a need for improved performance or strategies to boost investor confidence.

Insider Transactions:

Insider Transactions for ACI
Insider Transactions for ACI


1 purchases of ACI were executed, with market price of 627.5499877929688.During the period under consideration, no buy transactions took place.ACI's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.

Recommendation changes over time:

Recommendations trend for ACI
Recommendations trend for ACI


Archean Chemical Industries Limited has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view Archean Chemical Industries Limited as a stable option to park their money and potentially benefit from the company's continued growth and profitability.